Rationale: Pigmented lesions of conjunctiva and cornea can be observed in various conditions, from the benign nevus to malignant melanoma. Pigmented acquired melanosis (PAM) is one of them, which is a neoplastic proliferation with malignant transformation potential of melanocytes. However, to our knowledge, there has been no report as to a disturbance of corneal barrier function caused by PAM. Here we report a case of corneal PAM which led to recurrent corneal erosions.
Introduction
Pigmented lesions of conjunctiva and cornea can be observed in various conditions, from the benign nevus to malignant melanoma. [1] Primary acquired melanosis (PAM) is one of them, which is a neoplastic proliferation with the potentcy of malignant transformation. [1] However, there has been no report as to a disturbance of corneal barrier function caused by PAM so far. In this case report, we present a corneal dysplastic melanosis which led to recurrent corneal erosions. The patient provided informed consent for publication of the case, and the study was approved by the institutional review board of the Seoul National University Hospital (IRB No. 1711-139-902).
Case presentation
A 60-year-old woman was referred to our clinic because of intractable recurrent corneal erosions of overlying corneal pigmented lesions in the left eye. She mentioned that the corneal erosions were initially detected 4 months ago, because of a pain in the eye, blurred vision and photophobia. In spite of wearing therapeutic contact lens, the corneal erosions had recurred several times. The patient denied any underlying disease, including diabetes, ocular trauma, and prior ophthalmic history. The visual acuity was 20/20 in the right eye and 20/25 in the left eye. The intraocular pressure in both eyes was in the normal range. Slit-lamp examination of the left eye showed diffuse coarse pigmentations located in the corneal epithelial layer, scattered at peripheral limbus (1-8 o'clock), encroaching to the central cornea threatening visual axis (Figs. 1A, B) . A few small epithelial defects with loose irregular epithelium of overlying the pigmented lesion were observed (Fig. 1C) . The cornea in the right eye looked clear. Conventional conservative treatment for recurrent corneal erosion syndrome (RES) using a therapeutic contact lens (ACUVUE OASYS; Johnson&Johnson Vision Care, Inc., Jacksonville, FL; Base curve radius 8.80 mm) was initially tried. Gatifloxacin eyedrops (Gatiflo; 0.3% gatifloxacin; Handok, Seoul, Korea) was prescribed 4 times a day for 2 weeks. The 100 mg of oral doxycycline twice a day and 1000 mg of vitamin C 3 times a day were also prescribed. After 2 weeks, corneal epithelial erosions and epithelial loosening were still persistent, although the size of the epithelial defect was decreased (Fig. 1D, E) . To exclude a malignancy, the patient underwent en bloc epitheliectomy of the pigmented lesion followed by cryotherapy to the involved limbus (1-8 o/c) with temporary amniotic membrane transplantation (Fig. 1F) . During the surgery, all of the epithelium of the pigmentated lesion was very loose and separated easily from the stromal bed without any adhesion. The stroma was clear with no pigmentation. After the epitheliectomy, RES and loosened epithelial area completely subsided (Fig. 1G , H). The visual acuity was recovered to 20/20. The epithelial surface was maintained smoothly for 9 months. One week after the surgery, the pigmented lesions slightly recurred at 7-8 o'clock of the peripheral cornea involving limbus. However, up to the last visit, the recurred pigmentations were limited to the small peripheral area and did not induce any corneal erosion. (Fig. 1I ). For the recurred lesion, topical interferon a-2b eyedrops (2 million IU/ ml) and additional epitheliectomy with cryotherapy were tried but showed no effect.
In H&E stainings, scattered melanocytes in the basal epithelial layer and free-floating melanin pigmentations were observed. (Fig. 2A) . Cellular atypia was mild according to the criteria employed in previous reports from the Armed Forces Institute of Pathology (AFIP). [1] In immunohistochemistry staining, Melan A/MART-1 was detected in a few cells (Fig. 2B) , and Ki-67 proliferation index was low. The S100 and CD68 staining were negative (Fig. 2C, D) . In addition, BRAF gene mutation was not observed. Based on the histopathological findings, it was diagnosed as a corneal PAM with mild atypia. However, given that this case was accompanied with recurrent corneal erosions and loose epithelium, it suggests that PAM may disturb corneal epithelial barrier function. Considering the clinical and histopathologic findings, we finally diagnosed it as a dysplastic corneal PAM which led to epithelial dysfunction.
Discussion
The PAM is known to arise from melanocytes in the conjunctival epithelium. Conjunctival PAM is typically observed in the unilateral eyes of middle-aged Caucasians. [1] Melanocytic proliferations in corneal tissue were reported occasionally, mostly in patients with prior history of trauma or conjunctival PAM or malignant melanoma. [2] [3] [4] However, to our knowledge, there has been no report as to a corneal epithelial barrier dysfunction accompanied by corneal PAM. This is the 1st case report of corneal PAM which led to recurrent corneal erosions.
Because the pigmented lesion with epithelial erosions involved almost half of the cornea and 2/3rd of the limbus, we should exclude a malignancy at 1st. Therefore, we biopsied to exclude malignant melanoma. In the histologic examination, surprisingly, it turned out to be PAM with mild atypia. Immunohistochemical stains for S100, Melan A/MART-1, HMB-45, CD68 and Ki-67 were performed to enhance the accuracy of the diagnosis. Melan A/MART-1, HMB-45 and S100 are useful markers to identify cells of the melanocytic lineage and expressed in the majority of benign or malignant melanocytic lesions. [5, 6] Immunostaining for CD68 helps distinguish melanophage from melanocytic cells. [6] The Ki-67 proliferation index tends to be high in malignant melanoma. [3, 5] For example, Ki-67 was expressed less than 10% in the benign lesion. [3, 6] In addition, the detection of BRAF mutation could contribute to the diagnosis of conjunctival melanoma in the early stage. [7] The BRAF mutations were more frequently observed in conjunctival melanoma originating from a nevus (16/27; 57%) than those from PAM with atypia (22/69; 32%) or de novo (1/12; 8%) (P = .005). [7] Our case showed positive expression of Melan A/MART-1, and negative expression of CD68. The Ki-67 proliferation index was low (data not shown) and BRAF mutation was not observed, which is not indicative of high grade dysplasia. Additional staining could not be conducted due to a small amount of the tissue.
The PAM with atypia is considered as a premalignant lesion and histopathologic evaluation is essential for predicting prognosis. Conjunctival PAM is divided into 3 subgroups depending on the severity of atypia. [1] When the atypical melanocytes are mostly confined to the basal layer of the epithelium, it is graded as a PAM with mild atypia. If the atypical melanocytes extend into the non-basal epithelium in a pagetoid fashion, it is graded as a PAM with severe atypia. Shields et al [8] reported that 35% of PAM lesions progressed clinically over a 10-year interval and 13% of the eyes with PAM with severe atypia underwent malignant transformation. Not only the histopathologic findings but also the extent of the PAM lesions is highly correlated with the rate of development of malignancy. [8] Therefore, complete surgical excision followed by cryotherapy is generally recommended for the extensive areas of PAM occupying more than 2 clock hours.
To our knowledge, PAM in the subjects without an ocular trauma history has not been reported to cause RES. [3] Nevertheless, given that the corneal epithelial loosening and erosions regressed after the surgical excision of the PAM lesion while the conventional supportive treatment for RES had failed, PAM may be a plausible factor for RES. The defect in the epithelial junctional complex and basement membrane is one of the major causes of RES. [9] However, in this study, we can't determine whether the PAM lesion directly disrupted the epithelial adhesion complexes as the immunostaining for the adhesion molecules was not performed. The other possible explanation for the development of RES is the disruption of epithelial tight junctions, which might be caused by mitotic melanocytes in the PAM lesion. However, due to the lack of experimental data to support this explanation, further evalua- tions should be performed to reveal the mechanism of the PAM leading epithelial barrier dysfunction or delayed re-epithelization. Taken together, we found that the clinical findings of this case did not match with the histological findings. There is no definite evidence of malignancy or pre-malignant lesion in the histopathological examination. However, we cannot completely exclude them due to the small size of the resected tissue and low cellularity. Furthermore, given that the pigmented lesion was accompanied by disruption of the epithelial barrier and recurred promptly after the complete excision, we considered this case as a dysplastic PAM with a malignant potency. To detect the possible malignant transformation, the patient should be closely monitored. This case is worthy of notice because it is the 1st reported case of primary acquired corneal melanosis with accompanying functional abnormalities of the corneal epithelial cells leading to recurrent corneal erosions while appearing as histologically benign.
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